PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 102 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $931,000 | -21.5% | 315,293 | -16.0% | 0.46% | -28.2% |
| Q3 2015 | $1,186,000 | -48.4% | 375,293 | -3.3% | 0.64% | -37.6% |
| Q2 2015 | $2,297,000 | -70.2% | 388,000 | -46.2% | 1.02% | -70.0% |
| Q1 2015 | $7,703,000 | +8.2% | 720,553 | -5.0% | 3.41% | -0.4% |
| Q4 2014 | $7,119,000 | +16.6% | 758,233 | -4.6% | 3.42% | +13.3% |
| Q3 2014 | $6,103,000 | +7.1% | 794,658 | +25.2% | 3.02% | +15.3% |
| Q2 2014 | $5,701,000 | – | 634,753 | – | 2.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,010,000 | $905,000 | 0.21% |
| GLOBEFLEX CAPITAL L P | 226,959 | $102,000 | 0.03% |
| ACUTA CAPITAL PARTNERS, LLC | 62,800 | $28,000 | 0.01% |
| MENTA CAPITAL LLC | 195,136 | $87,000 | 0.01% |
| Orbimed Advisors | 1,073,000 | $481,000 | 0.01% |
| GOODWIN DANIEL L | 22,679 | $10,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 215,800 | $97,000 | 0.00% |
| Renaissance Technologies | 2,214,396 | $992,000 | 0.00% |
| STOCK YARDS BANK & TRUST CO | 30,170 | $14,000 | 0.00% |
| HIGHLAND CAPITAL MANAGEMENT, LLC | 41,000 | $18,000 | 0.00% |